Description

FALCIMEF TAB is an oral antimalarial formulation containing Mefloquine Hydrochloride, a potent antiprotozoal agent widely used for the treatment and prophylaxis of malaria, particularly strains resistant to other therapies like chloroquine. Mefloquine is effective against Plasmodium falciparum, the most severe form of malaria parasite, and is recognized for its long half-life, allowing once-weekly dosing for prophylaxis or single-dose treatment in certain cases.

Mefloquine interferes with the parasite’s ability to degrade and utilize hemoglobin, ultimately leading to its death. It is recommended in both traveler’s malaria prevention and endemic zone treatment strategies, especially in regions with known drug resistance.

Therapeutic Applications:

• Treatment of uncomplicated Plasmodium falciparum malaria

• Prophylaxis for travelers visiting malaria-endemic regions

• Alternative therapy for chloroquine-resistant malaria

• Malaria control in public health and emergency settings

Key Benefits:

• Broad-spectrum antimalarial coverage

• Effective in single-dose or weekly prophylaxis

• Active against chloroquine-resistant strains

• Long-lasting protection in endemic zones

• Easy oral administration and traveler-friendly formulation

Manufactured under WHO-GMP and ISO-certified facilities, FALCIMEF TAB meets international quality and regulatory standards. It is represented globally by BLUEPILL EXPRESS, a reliable exporter serving clients across Asia, Africa, Latin America, Europe, and the Middle East. With extensive expertise in antimalarial drug logistics and compliance, BLUEPILL EXPRESS ensures timely delivery and full documentation support for public and private sector distribution.